INFRARED ANALYSIS OF PERIPHERAL BLOOD FRACTIONS OBTAINED TO INDICATE COGNITIVE DEVELOPMENT ASSOCIATED WITH ALZHEIMER'S DISEASE

The present invention relates to a method for transmission infrared spectroscopic analysis for determining the degree of global cognitive impairment associated with Alzheimer's disease based on analyzing the 3100-1300 cm -1 infrared spectrum region of a previously obtained and fractionated samp...

Full description

Saved in:
Bibliographic Details
Main Authors CARMONA HERNÁNDEZ, PEDRO, MARTÍNEZ MARTÍN, PABLO, TOLEDANO GASCA, ADOLFO, CALERO LARA, MIGUEL, BERMEJO PAREJA, FÉLIX
Format Patent
LanguageEnglish
French
German
Published 18.06.2014
Subjects
DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SURGERY
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method for transmission infrared spectroscopic analysis for determining the degree of global cognitive impairment associated with Alzheimer's disease based on analyzing the 3100-1300 cm -1 infrared spectrum region of a previously obtained and fractionated sample of blood. Preferably, the fractionated sample of blood to be analyzed is a fraction of leukocytes. Likewise, another object of the present invention relates to the use of said method to obtain an indication of the status of the Alzheimer's disease and/or an indication of the degree of cognitive impairment associated with said disease.
Bibliography:Application Number: EP20120821746